ARCHIVES

Prevention Trial Could Stand On Its Own

This article is from The Cancer Letter archive.

Vol. 20 No. 41 | October 28, 1994

Download PDF Visit The Full Archive

Related Articles

In Brief: visco Named to Cancer Policy Board; Foundation Pledges $6.5 Million to Karmanos

May 9, 1997

NCI Planning Phase III Study Of Avastin For Metastatic Colorectal Cancer

June 27, 2003

NCI Director Klausner Resigns To Head Institute Begun By AOL Chairman Case.

September 14, 2001

DCT Board Approves Phase 2/3 Studies Of LAK-IL-2

February 14, 1986

In Brief: Jordan To Join MD Anderson Cancer Center

July 25, 2014

Fewer, Larger RT Doses Cut Recurrence Of Early Breast Cancer, UK Study Finds

June 29, 2007